Literature DB >> 16237952

Serum C-reactive protein and complement proteins in patients with acute myocardial infarction.

Youssef A Halas1, Elias Rahal, Alexander M Abdelnoor, Raja Haddad, Antoine Abchee.   

Abstract

C-reactive protein (CRP) and complement proteins levels were determined in 20 patients with acute myocardial infarction (AMI) and 20 controls. Blood was obtained from all subjects at admission, 6 hr and 12 hr later. Serum CRP levels were determined by ELISA and complement proteins by radial immunodiffusion. A statistically significant elevation of the mean CRP level was obtained at 12 hr postadmission. The mean complement proteins levels were 16-49% higher in AMI patients than the controls. It appeared that the alternate pathway was activated initially, followed by activation of the classical pathway. The increased levels of CRP and complement proteins are suggestive of their involvement in AMI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237952     DOI: 10.1080/08923970500241006

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  4 in total

1.  Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.

Authors:  Gongxiong Wu; Weiguo Hu; Aliakbar Shahsafaei; Wenping Song; Martin Dobarro; Galina K Sukhova; Rod R Bronson; Guo-Ping Shi; Russell P Rother; Jose A Halperin; Xuebin Qin
Journal:  Circ Res       Date:  2009-01-08       Impact factor: 17.367

2.  Bioactive Sphingolipids, Complement Cascade, and Free Hemoglobin Levels in Stable Coronary Artery Disease and Acute Myocardial Infarction.

Authors:  T Jadczyk; K Baranski; M Syzdol; E Nabialek; W Wanha; R Kurzelowski; M Z Ratajczak; M Kucia; B Dolegowska; M Niewczas; J Zejda; W Wojakowski
Journal:  Mediators Inflamm       Date:  2018-07-09       Impact factor: 4.711

3.  Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice.

Authors:  Shen Dai; Fengming Liu; Mi Ren; Zhongnan Qin; Namita Rout; Xiao-Feng Yang; Hong Wang; Stephen Tomlinson; Xuebin Qin
Journal:  Front Cardiovasc Med       Date:  2021-09-28

4.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.